BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VTIMEZONE TZID:America/Denver X-LIC-LOCATION:America/Denver BEGIN:DAYLIGHT TZOFFSETFROM:-0700 TZOFFSETTO:-0600 TZNAME:MDT DTSTART:19700308T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0600 TZOFFSETTO:-0700 TZNAME:MST DTSTART:19701101T020000 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT UID:ece1ee9b494769a81c8c771fcbc28b2f90 CATEGORIES:Annual Meeting SUMMARY:Topics in Prescriptive Authority Webinar Series DESCRIPTION:
Please join us for a series of webinars exploring
topics in Clinical Psychopharmacology. Our featured speaker is Dr. Judith
Steinman, PhD. As past-President of APA Division 55 and Program Director fo
r the nation’s first Postdoctoral Master of Science in Clinical Psychopharm
acology, Dr. Steinman will share with you her experience in the field and t
he importance of prescriptive authority for improved behavioral mental heal
th access.
Wednesday | Sep 16 | 4:00 PM PT
• Ne
w Horizons - Clinical Psychopharmacology as a Recognized APA Specialty and
Moving Towards Board Certification
On August 8, 2020, the Am
erican Society for the Advancement of Pharmacotherapy (ASAP) was recognized
as a Specialty by the American Psychological Association (APA) Council of
Representatives. This historic accomplishment sets the stage for Clinical P
sychopharmacologists who are licensed to prescribe to become board certifie
d. Academic and experiential pathways to becoming a Prescribing Clinical Ps
ychopharmacologist will be discussed.
Monday | Oct 19 | 4:00 PM PT
• Ne
uroscience and Psychopharmacology in the Era of COVID19
The pace at which the hea lth and financial consequences of COVID19 have pervaded society has left us in an overwhelming state of stress. Science and medicine have generated th eories that normally are tested over time, but the precipitous climb of mor tality and morbidity left us scrambling for answers and hanging our hopes o n treatments that ultimately proved ineffective or in some cases hazardous. This presentation will parse out the scientific facts from theory regardin g neurological sequelae of COVID19 exposure and how medications prescribed for mental health conditions may interact with treatments used for COVID19.
Tuesday | Nov 10 |
4:00 PM PT
• Ethnic and Cultural Disparities in Pharmacotherapy for Me
ntal Health Disorders
Factors such as ethnicity, gender, age, skin color and have
a substantial impact on how patients respond to behavioral therapy and phar
macotherapy. Influences from cultural perceptions to differences in liver e
nzyme polymorphisms can assist Prescribing Psychologists in determining opt
imal medication choices or when behavioral therapy may be more suitable tha
n pharmacotherapy. Attendees will gain an understanding of the complex cult
ural and genetic factors that affect medication response.
For more information contact
Marj
orie Boidy • Assoc. Director of Online Admissions
marjorie.boidy@alliant.edu | 858-635-4749